Fertin Pharma

Fertin helps leading global brands create pharmaceutical and nutraceutical products to support healthier living. We develop and manufacture innovative oral and intra-oral delivery systems that enhance the efficacy of your active and functional ingredients – without compromising on taste-masking, texture and the consumer experience.

With more than 800 employees across our R&D centres and manufacturing facilities in Canada, Denmark and India, we produce approximately 3 billion units a year, used by consumers all over the world.

Fertin was acquired by Philip Morris International on July 1, 2021.